Press Releases

Dec 01, 2021
SIGA Announces Health Canada Regulatory Approval of Oral TPOXX®
NEW YORK , Dec. 01, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Health Canada has approved oral TPOXX® (tecovirimat) as an extraordinary use new drug.
Sep 07, 2021
SIGA Technologies CEO to Speak at NCT USA Conference September 8, 2021
NEW YORK , Sept. 07, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that Dr. Phil Gomez , the Company’s Chief Executive Officer, will be a speaker at the NCT USA conference on September 8 , in Baltimore , Maryland. 
Aug 05, 2021
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2021
- Approximately $7 Million in International Sales of Oral TPOXX® in the Second Quarter – - Authorization of Additional $50 Million Share Repurchase Program - - Corpor ate Update Conference Call Today at 4:30 PM ET   NEW YORK , Aug. 05, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc.
Displaying 1 - 10 of 19